Navigation Links
SFU HIV/AIDS vaccine research gets financial boost
Date:4/3/2012

Jamie Scott, a Simon Fraser University professor and Canada Research Chair in molecular immunity, and three international collaborators are getting a hefty financial boost in their efforts to develop an effective HIV/AIDS vaccine.

The United States National Institutes of Health (NIH) has awarded the four researchers $2.7 million to help them improve the effectiveness of a DNA-based vaccine that Marinieve Montero first conceived of eight years ago. Montero was a student of Scott's whose work was also funded by the NIH, the U.S.'s largest government-funded medical research agency.

Scott's current collaborators are at the University of the Basque Country, the University of Massachusetts School of Medicine and the University of California, San Francisco.

The researchers will use their new funding to strengthen a vaccine they've made from a DNA fragment taken from the HIV genome. The fragment encodes something that is highly prized in HIV/AIDS vaccine research. Called the MPER, it's a region of the HIV envelope that retains mutations at a very low level compared to the rest of the virus's genome, which continually mutates.

The MPER doesn't retain mutations because they would hamper the virus's ability to infect cells and duplicate itself.

"The real challenge to creating antibodies that fight a constantly mutating virus like HIV," explains Scott, "is finding a region on the virus's surface protein that rarely mutates. That provides an exposed site that does not change from virus to virus and that antibodies can attack. The MPER is such a site."

While other researchers have made vaccines that expose a subject's immune system to a synthetic version of the MPER, the vaccines have not triggered the production of antibodies that recognize and attack HIV.

Scott and her partners believe this is because synthetic MPER vaccines to-date have not replicated the viral MPER accurately, but say their new vaccines do a better job.

During the next four years, the researchers will test their improved MPER vaccines, which they hope will induce antibodies that are aggressive enough to prevent HIV from infecting lab subjects.


'/>"/>

Contact: Carol Thorbes
cthorbes@sfu.ca
778-782-3035
Simon Fraser University
Source:Eurekalert

Related biology news :

1. CWRU study finds the love of a dog or cat helps women cope with HIV/AIDS
2. HIV/AIDS vaccine developed at Western proceeding to human clinical trials
3. Tropical disease experts report missed opportunity to transform global HIV/AIDS fight
4. Scripps Florida scientist awarded $3.4 million for HIV/AIDS research
5. A Trojan horse in the fight against HIV/AIDS
6. Plenary speakers address challenges in the delivery of sustained antiretroviral therapy in developing countries, call for social scientists to take their place at the HIV/AIDS policy-making table, and stress the need for a long-term response to AIDS
7. 2020 vision of vaccines for malaria, TB and HIV/AIDS
8. Advances in HIV/AIDS prevention and treatment
9. Using hair to manage HIV/AIDS and predict treatment success
10. Cutting-edge amfAR grants fight HIV/AIDS in the lab and on the phone
11. NTDs burden in Latin America and the Caribbean may exceed that of HIV/AIDS, TB and malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
(Date:3/23/2017)... , March 23, 2017 The report "Gesture Recognition and ... Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, the market ... CAGR of 29.63% between 2017 and 2022. Continue ... ... ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... time members of the Modular Building Institute (MBI), an international modular trade organization, ... the permanent modular category for the Pagliuca Life Lab at Harvard University. The ...
(Date:3/28/2017)... March 28, 2017  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... of novel therapies for metabolic and endocrine disorders, today ... , Ph.D., will deliver a corporate presentation at H.C. ... Conference, being held April 3, 2017 at the St. ... for this presentation are as follows: ...
(Date:3/28/2017)... YORK , March 28, 2017 ... highly volatile and unpredictable sector due to the ... Markets served include medical, agricultural, environmental, and industrial. In ... four stocks: Portola Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience ... and Ocular Therapeutix Inc. (NASDAQ: OCUL ...
(Date:3/27/2017)... WARREN, N.J. , March 27, 2017 Roka ... providing advanced testing solutions for the detection of foodborne pathogens, ... at the Sidoti & Company Spring 2017 Convention on March ... the New York Marriott Marquis. About Roka ... ...
Breaking Biology Technology: